TRIAP1 and neoplasm: The proteomic analyses revealed that the combination treatment significantly downregulated tumour-promoting genes such as HLA-F, TRIAP1, TMBIM6, and ENTPD8, suggesting reduced mitochondrial integrity and immune escape, thereby enhancing apoptotic susceptibility.